Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Nicox S.A (PA: COX)

 
COX Technical Analysis
5
As on 27th Apr 2023 COX STOCK Price closed @ 0.58 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.07 & Strong Sell for SHORT-TERM with Stoploss of 2.70 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

COXSTOCK Price

Open 0.64 Change Price %
High 0.64 1 Day 0.00 0.00
Low 0.58 1 Week -0.10 -14.71
Close 0.58 1 Month -0.14 -19.44
Volume 239029 1 Year -2.55 -81.47
52 Week High 3.14 | 52 Week Low 0.55
 
PA France Most Active Stocks
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
ALMAS 0.02 %
ACA 14.55 0.97%
ALAGO 0.32 14.29%
ORA 10.41 -0.29%
ALEUP 0.01 0.00%
ENGI 16.14 1.38%
CGG 0.69 -2.82%
BNP 67.05 4.24%
 
PA France Top Gainers Stocks
ALMII 8.15 116.76%
MLOCT 0.19 35.71%
ALTRO 5.35 24.42%
ALLLN 1.36 21.43%
MLNMA 0.07 16.67%
ALAGO 0.32 14.29%
DBV 0.88 12.82%
DBV 0.88 12.82%
DBV 0.88 12.82%
ALBDM 0.85 11.84%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
ALMDT 3.35 -17.69%
FIPP 0.12 -14.29%
FIPP 0.12 -14.29%
FIPP 0.12 -14.29%
ORP 7.90 -12.03%
MLMON 0.88 -12.00%
ALDNE 1.12 -11.81%
 
 
COX
Daily Charts		 COX
Intraday Charts		 Whats New @
Bazaartrend		 COX
Free Analysis
 
COX Important Levels Intraday
RESISTANCE0.70
RESISTANCE0.66
RESISTANCE0.64
RESISTANCE0.61
SUPPORT0.55
SUPPORT0.52
SUPPORT0.50
SUPPORT0.46
 
COX Forecast February 2025
Share
4th UP Forecast1.72
3rd UP Forecast1.35
2nd UP Forecast1.13
1st UP Forecast0.9
1st DOWN Forecast0.26
2nd DOWN Forecast0.03
3rd DOWN Forecast-0.19
4th DOWN Forecast-0.56
 
COX Weekly Forecast
4th UP Forecast0.97
3rd UP Forecast0.84
2nd UP Forecast0.77
1st UP Forecast0.69
1st DOWN Forecast0.47
2nd DOWN Forecast0.39
3rd DOWN Forecast0.32
4th DOWN Forecast0.19
 
COX Forecast2025
4th UP Forecast5.57
3rd UP Forecast3.97
2nd UP Forecast2.98
1st UP Forecast1.99
1st DOWN Forecast-0.83
2nd DOWN Forecast-1.82
3rd DOWN Forecast-2.81
4th DOWN Forecast-4.41
 
 
COX Other Details
Segment EQ
Market Capital 116985336.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
COX Address
COX
 
COX Latest News
 
Your Comments and Response on Nicox S.A
 
COX Business Profile
Nicox S.A., an international ophthalmology company, develops innovative solutions to help maintain vision and improve ocular health. Its lead program in clinical development, NCX 470, a novel nitric oxide-donating prostaglandin analog, is in Phase 3 clinical trials for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company is also developing NCX 4251, a novel patented ophthalmic suspension of fluticasone propionate nanocrystals, which is in a Phase 2b clinical trial for the treatment of acute exacerbations of blepharitis. It markets VYZULTA in glaucoma, licensed exclusively worldwide to Bausch + Lomb; and ZERVIATE in allergic conjunctivitis licensed in various geographies, including to Eyevance Pharmaceuticals, LLC in the United States, and Ocumension Therapeutics in the Chinese and in the South East Asian markets. Nicox S.A. was founded in 1996 and is headquartered in Valbonne, France. Address: Drakkar 2 BAt D, Valbonne, France, 06560
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service